Investors
Chas Pulido
General Partner
“No great feat has ever been accomplished in isolation, it truly takes a village - always lend a helping hand to others as they will help you along the journey”
Chas Pulido is a 3rd generation healthcare CEO, serial entrepreneur, & venture capitalist with a passion for helping startups drive patient impact.
Chas founded Alix Ventures, where he serves as General Partner, to support high potential early stage Life Science startups engineering biology to drive radical advances in human health. He is particularly excited about startups at the intersection of technology & biology, known as “TechBio”, building platforms for “Novel Applications” (Therapeutics/Diagnostics) & “Bio-Economy Infrastructure” (Services/Manufacturing).
Recognizing the TechBio movement at hand, Chas created BIOS - Content & community platform to unite Life Science industry innovators. To learn more about BIOS & initiatives check out: BIOS Medium (Top Writer: Venture Capital), BIOS Podcast (Top 5 Life Sciences), BIOS Daily Newsletter (25K+ Subscribers), BIOS Angels (World’s 1st TechBio Angel Investing Syndicate), & join our community - BIOS Commons (1000+ Members).
Chas started his foray into venture capital with the opportunity to support Healthcare/Life Science (HC/LS) investments at Liquid 2 Ventures (L2V), led by Joe Montana - Hall of Fame Quarterback, a leading early stage VC fund focused on backing breakout founders - 750+ portfolio companies including standout HC/LS startups such as: Nurx, Truepill, Cerebral, Athelas, Solugen, H1 Insights, Cricket, Lively, Culture, Herophilus, amongst others. While @ L2V, Chas spent his time sourcing/diligencing new investments & helping portfolio founders excel in business development, hiring, & fundraising.
Chas began his entrepreneurial pursuits at The University of Notre Dame where he majored in Management Consulting and served as an Innovation Fellow. His interests took him west to Silicon Valley through Y-Combinator with the founding of Pareto Life Sciences, the world’s first stem cell marketplace. In an effort to help patients access breakthrough treatments, he joined Clara Health (Acquired by M&B Sciences) - a leading clinical trial innovation startup - as an early employee to head business development & operations.
Outside of work, you can find Chas exploring his creativity while cooking, painting, glassblowing, or roaming about hiking, exploring museums, & traveling (70+ Countries/7 Continents).